Skip to content
Menu

Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $178

Benzinga Newsdesk 1 month ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $180 to $178.

Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $180 to $178.

Read at benzinga.com

← All stock news